Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
Differential diagnosis: imaging to tell the difference Brain imaging could be used to distinguish between patients with corticobasal degeneration (CBD) and Parkinson's disease (PD). CBD is a rare condition caused by the gradual loss of brain cells in areas of the brain that link thinking to mov...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3dc9ce18e36a4930aa2c9587c7f870cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3dc9ce18e36a4930aa2c9587c7f870cd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3dc9ce18e36a4930aa2c9587c7f870cd2021-12-02T11:42:13ZDisentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses10.1038/s41531-017-0012-62373-8057https://doaj.org/article/3dc9ce18e36a4930aa2c9587c7f870cd2017-03-01T00:00:00Zhttps://doi.org/10.1038/s41531-017-0012-6https://doaj.org/toc/2373-8057Differential diagnosis: imaging to tell the difference Brain imaging could be used to distinguish between patients with corticobasal degeneration (CBD) and Parkinson's disease (PD). CBD is a rare condition caused by the gradual loss of brain cells in areas of the brain that link thinking to movement. The clinical features of CBD, referred to as corticobasal syndrome (CBS), are similar to those of patients with PD, but they progress differently. To aid earlier and more accurate diagnosis, Franziska Albrecht, at the Max Planck Institute for Human Cognitive and Brain Sciences, Germany, and colleagues reviewed 11 magnetic resonance imaging studies to find brain areas that are specifically affected in CBS/CBD patients. They show that cell loss in specific regions of the motor areas and frontomedian cortex is a hallmark of CBS/CBD, whereas cell loss in the thalamus and parts of the frontal/precentral gyrus were associated with other neurodegenerative diseases.Franziska AlbrechtSandrine BiseniusRodrigo Morales SchaackJane NeumannMatthias L. SchroeterNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 3, Iss 1, Pp 1-8 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurology. Diseases of the nervous system RC346-429 Franziska Albrecht Sandrine Bisenius Rodrigo Morales Schaack Jane Neumann Matthias L. Schroeter Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses |
description |
Differential diagnosis: imaging to tell the difference Brain imaging could be used to distinguish between patients with corticobasal degeneration (CBD) and Parkinson's disease (PD). CBD is a rare condition caused by the gradual loss of brain cells in areas of the brain that link thinking to movement. The clinical features of CBD, referred to as corticobasal syndrome (CBS), are similar to those of patients with PD, but they progress differently. To aid earlier and more accurate diagnosis, Franziska Albrecht, at the Max Planck Institute for Human Cognitive and Brain Sciences, Germany, and colleagues reviewed 11 magnetic resonance imaging studies to find brain areas that are specifically affected in CBS/CBD patients. They show that cell loss in specific regions of the motor areas and frontomedian cortex is a hallmark of CBS/CBD, whereas cell loss in the thalamus and parts of the frontal/precentral gyrus were associated with other neurodegenerative diseases. |
format |
article |
author |
Franziska Albrecht Sandrine Bisenius Rodrigo Morales Schaack Jane Neumann Matthias L. Schroeter |
author_facet |
Franziska Albrecht Sandrine Bisenius Rodrigo Morales Schaack Jane Neumann Matthias L. Schroeter |
author_sort |
Franziska Albrecht |
title |
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses |
title_short |
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses |
title_full |
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses |
title_fullStr |
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses |
title_full_unstemmed |
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses |
title_sort |
disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ale meta-analyses |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/3dc9ce18e36a4930aa2c9587c7f870cd |
work_keys_str_mv |
AT franziskaalbrecht disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses AT sandrinebisenius disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses AT rodrigomoralesschaack disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses AT janeneumann disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses AT matthiaslschroeter disentanglingtheneuralcorrelatesofcorticobasalsyndromeandcorticobasaldegenerationwithsystematicandquantitativealemetaanalyses |
_version_ |
1718395335802355712 |